Mark Hammond

@andrewwhite01 What's your strategy for sorting though the output to check accuracy besides the written report? Results from my first run feel overwhelming in the number of tasks and artifacts. It's hard to find an overall view of their dependencies like a formal workflow.

I would like to share the first insanely good example of a novel idea derived from the o1-pro model for a cancer therapy project I am working on. Perhaps I’ll do one of these for 12 days. 😊 Introduction to the Context: I’m working on developing innovative cancer immunotherapy approaches to address key challenges in the field. Immunotherapy is an exceptionally powerful strategy for curing cancer because it harnesses the body’s immune system—our internal army—and empowers it to recognize and eliminate cancer cells. In this effort, we are focusing on engineering T cells, the immune system’s soldiers and generals, through synthetic biology. However, significant challenges remain, especially in treating solid tumors like breast cancer. Within the tumor microenvironment, T cells often become exhausted due to the overwhelming number of cancer cells and the suppressive environment created by the tumor. This exhaustion severely limits the effectiveness of these therapies. To tackle this issue, we employ a cutting-edge model system using 3D bioprinted breast cancer tissue integrated with engineered human T cells. These T cells are reprogrammed through advanced synthetic biology techniques to test and develop solutions for overcoming exhaustion. Prompt to O1-Pro: Building on work I’ve previously done and tested with o1-Preview and GPT-4o, I posed the following prompt: “I’d like you to focus on 3D bioprinted solid tumors as a model to address the T cell exhaustion problem. Specifically, the model should incorporate stroma, as seen in breast cancer, to replicate the tumor microenvironment and explore potential solutions. These solutions could involve technologies like T cell reprogramming, synthetic biology circuits, cytokines, transcription factors related to exhaustion, or metabolic programming. Draw inspiration from other fields, such as Battle Royale games or the immune system’s ability to clear infected cells without triggering autoimmunity. Identify potential pitfalls in developing these therapies and propose alternative approaches. Think outside the box and outline iterative goals that could evolve into full-scale projects. Focus exclusively on in vitro human systems and models.” Why Battle Royale Games? You might wonder why I referenced Battle Royale games. That’s precisely the point—I wanted to push the model to think beyond conventional approaches and draw from completely different systems for inspiration. While o1-Preview and GPT-4o were able to generate some interesting ideas based on this concept, but they were mostly what I could also conceive though better most PhD students. In contrast, o1-Pro came up with far more creative and innovative solutions, that left me in awe! Idea #9: A Remarkable Paradigm Here, I’m sharing one specific idea, which I’ll call Idea #9 based on its iteration sequence. This idea was exceptional because it proposed an extraordinary paradigm inspired by Battle Royale games but more importantly within the context of deep temporal understanding of biological processes. This was the first time any model explicitly considered the time-dependent nature of biological events—an insight that reflects a remarkably advanced and nuanced understanding! “Adapt or Fail” Under Escalating Challenges: Another remarkable aspect of idea #9 was that conceptually it drew from the idea of “adapt or fail” in escalating challenges, directly inspired by Battle Royale mechanics. This was the first time any model could think of it from this perspective. It also emphasized the importance of temporal intervals in reversing or eliminating exhausted T cells. Indeed, this approach mirrors the necessity for T cells to adapt dynamically under pressure and survive progressively tougher challenges, something we would love to model in in vitro systems! One particularly further striking insight was the role of stimulation intervals in preventing exhaustion. Idea #9 suggested that overly short intervals between stimuli might be a key factor driving T cell exhaustion in current therapies. This observation really amazed me with its precision and relevance—because it pinpointed a subtle but critical aspect of T cell activations and development of exhaustion mechanisms. Expanding the Idea: Following this, I then prompted o1-pro to expand its proposal into a detailed project outline and explain why the temporal roadmap was so significant. Its response, which I may need to unpack even in more detail later, was equally remarkable and demonstrated incredible depth. It expanded idea #9 not only as proposed actionable solutions but also laid out a framework for understanding the problem of temporal roadmap in a remarkable clarity! -------------- Here is the follow up response of o1-pro on the Project Concept with comments from me in parenthesis and italic : Title (Example): “Temporal Profiling and Strategic Interventions in Progressive T Cell Exhaustion in a Tumor Model.” Rationale: T cell exhaustion in solid tumors doesn’t occur instantaneously; it emerges over time as T cells face continuous, escalating immunosuppressive cues from the tumor microenvironment (TME). Traditional in vitro tumor models often fail to capture this dynamic progression, instead presenting a static “snapshot” of immune suppression. By introducing inhibitory signals at defined intervals, we can model the evolving landscape of a growing, mutating tumor and identify critical temporal “inflection points” where interventions can effectively reverse or prevent exhaustion. Understanding the temporal dynamics of T cell exhaustion is key to designing therapies that are timely, not just effective at a single point in time. (To me this is absolutely shocking level of insight, made me emotional reading it 🥺) Approach Overview: 3D Bioprinted Tumor Platform Setup Model Construction: Start with a 3D bioprinted structure that includes breast cancer cells and a supporting stroma composed of cancer-associated fibroblasts, ECM, and vascular-like channels for nutrient delivery. Initially, introduce T cells engineered for enhanced anti-tumor activity (e.g., CAR-T cells or TCR-engineered T cells) at Day 0. (This is exactly what we plan advance our model with a collaborator scientist colleague!) Baseline Assessment: At time zero, measure baseline T cell infiltration, cytokine profiles, and cell viability. Perform initial phenotyping (flow cytometry, confocal imaging) to confirm T cell activation and early-stage effector functions. (Perfect experimental approaches!) Sequential Introduction of Inhibitory Signals (The ‘Battle Royale’) Temporal Intervals: Introduce new layers of immunosuppression at defined intervals: for instance, every 3 days, add a new stressor or inhibitory molecule to the system. Example schedule: Day 0: Baseline tumor + T cells (no additional inhibitory signals). Day 3: Add PD-L1-overexpressing stromal cells or soluble PD-L1. (this is another remarkable insight, won't go into details but PD-L1 binding to PD1 on T cells is thought to be critical in T cell exhaustion) Day 6: Introduce MDSC-like cells or high concentrations of TGF-β. (this is an immune suppressive cytokine, rationale for adding this later is novel and I would not have thought about!) Day 9: Increase environmental hypoxia by adjusting oxygen-permeable membranes. (again mentioning this day 9 shows insight because hypoxia likely to develop at later time point) Escalating Complexity: Each introduced factor models a stage of tumor evolution. Early on, PD-1/PD-L1 interactions may dominate, but as time progresses, multiple layers of suppression stack (TGF-β, metabolic stressors, additional inhibitory receptors), mirroring a “last man standing” scenario where T cells must adapt or fail. Multiparametric Readouts at Each Time PointImaging and Flow Cytometry: At each stage (Day 3, 6, 9, 12, and beyond), collect samples for single-cell analysis. Measure T cell exhaustion markers (PD-1, TIM-3, LAG-3), metabolic states (mitochondrial mass, membrane potential), proliferation indices (Ki-67), and effector functions (IFN-γ, TNF-α production). (again great experimental approaches, only thing missing is cytotoxicity measurements towards cancer cells) Single-Cell RNA-seq and Metabolomics: Capture the transcriptional and metabolic shifts in T cells after each introduced inhibitory challenge. This provides insight into the timing of epigenetic reprogramming and exhaustion-associated transcription factor expression (TOX, NR4A family). (Also part of our planned experiments! This is state of the art technology) Temporal Roadmap Development Data Integration:Combine phenotypic, functional, transcriptomic, and metabolic data at each time point into a unified “temporal roadmap.” This roadmap would highlight when T cells undergo key state transitions: from active effector cells to partially dysfunctional and eventually to deeply exhausted phenotypes. (this left me speechless, it would require years of training and working on T cells to really understand the depth here, so cool!) Inflection Points Identification: Identify critical periods just before a major drop in cytokine production or just after a surge in inhibitory receptor expression. These inflection points represent windows where interventions could be maximally effective. (Love the inflection points concept, I gonna use this!) Strategic Interventions at Optimal Time Points Adaptive Therapy Administration: Once the roadmap is established, select the most promising interventions and apply them at predicted optimal times. For example: Just as PD-1 expression peaks, administer a short-pulsed anti-PD-1 nanocarrier. Prior to the introduction of TGF-β, pre-treat T cells with a synthetic biology circuit that upregulates metabolic resilience genes when they sense TGF-β. When transcriptomic data indicates impending epigenetic shutdown, deliver CRISPR/dCas9 epigenetic modulators to maintain TCF1 expression and prevent stable exhaustion states. (temporal interventions, should be the new paradigm in therapeutics!) Engineering T Cells for Temporal Responsiveness Synthetic Biology Circuits :Design T cells with logic-gated synthetic circuits that detect specific inhibitory cues and respond by boosting mitochondrial function, producing IL-15, or transiently blocking inhibitory receptor expression. By programming these cells to become more potent at just the right moment—e.g., when PD-L1 appears—they can remain functional longer. (I can write a whole section why I love this!) Controlled Metabolic Boosts: Include materials in the bioprinted matrix that gradually release metabolic substrates or IL-15 at times when T cells are predicted to be most vulnerable. This could be triggered by environmental changes, such as hypoxia sensors that release an IL-15 burst once O2 levels drop, refreshing T cell energy stores at a critical time. (Wow just wow, this is an idea I will implement for sure! How did it know IL-15 was important in this case?! Hope others working on the same topic doesn't steal it though 🤣) Predictive Modeling and Iterative Refinement AI-Driven Feedback Loops: Use computational modeling to predict future states of T cell exhaustion based on current data. Iteratively refine the timing and type of interventions. If T cells succumb to exhaustion faster than expected, adjust the schedule of inhibitory challenges or try different interventions at new time points. (Great idea! Need o1-pro for this :) Experimental Deliverables: A fully characterized temporal roadmap correlating inhibitory cue introduction with T cell functional decline. Identification of at least two or three “intervention windows” where timely treatments prevent the next stage of exhaustion. Demonstration that time-calibrated interventions can sustain T cell activity and tumor clearance potential for significantly longer periods than static treatment regimens. Why the Temporal Aspect is Critical: Dynamic Nature of Exhaustion: T cell exhaustion is not static; it unfolds as a result of chronic stimulation and cumulative inhibitory signaling. Understanding the timeline allows us to know not just what signals exhaust T cells, but when those signals are most damaging. Mimicking Tumor Evolution: Tumors evolve over time, adopting new mechanisms of immune evasion. A temporal model mirrors this evolutionary process, allowing therapies to be planned as if anticipating the tumor’s next move. Optimizing Intervention Efficacy: Interventions applied too late might fail because epigenetic changes have locked T cells into an exhausted state. Similarly, interventions too early might be unnecessary or could cause excessive activation and toxicity. Timing interventions optimizes efficacy and safety. Refinement and Personalization: A temporal roadmap helps translate these findings into clinically relevant strategies. One could envision patient-specific timelines, where computational models predict the onset of exhaustion, guiding real-time therapeutic adjustments (akin to immunotherapy “precision scheduling”). I have nothing else to add! I salute you o1-pro!

I've heard people claim that Sam is just drumming up hype, but from what I've seen everything he's saying matches the ~median view of @OpenAI researchers on the ground.